Tag Archive | "Valeant"

Actavis enters into a settlement agreement with Valeant

Tags: , ,

Actavis has entered into an agreement with Valeant Pharmaceuticals to settle all outstanding patent litigation related to Actavis' generic version of Acanya (clindamycin phosphate and benzoyl peroxide) Gel, 1.2%/2.5%. Read the full story

Allergan rejects Valeant’s acquisition offer

Tags: , , ,

Allergan announced that its Board of Directors has unanimously rejected the unsolicited proposal announced by Valeant Pharmaceuticals International, Inc.  on April 22, 2014. Read the full story

Will Allergan join Valeant’s list of acquisitions?

Tags: , , ,

Allergan is currently the subject of much speculation as Valeant Pharmaceuticals looks to acquire it. Valeant Pharmaceuticals, well known for building its company via acquisitions, put in a $46 billion bid one week ago to acquire Californian based botox maker Allergan. Read the full story

Big pharma, Valeant bids for a merger with Allergan

Tags: , , ,

Big Pharma, Valeant Pharmaceuticals International Team Up To Make $45.6 Billion Allergan Bid. Read the full story

Valeant signs a pharma alliance with Kadmon for Syprine

Tags: , ,

Kadmon Pharmaceuticals and Valeant Pharmaceuticals sign a phama alliance for co-promotion of Syprine in the US. Read the full story

Valeant and PreCision in M&A deal

Tags: ,

Valeant Pharma will acquire PreCision Dermatology for $475 million in cash, plus an additional $25 million payable upon achievement of a sales-based milestone Read the full story

Valeant, Actavis and Mylan fight over Pfizer’s Generic business

Tags: , , , , , ,

Drugmakers Valeant Pharmaceuticals International Inc , Actavis Plc and Mylan Inc have all expressed interest in buying Pfizer's branded generics business, but no active discussions are going on at this time, according to three people close to the matter. Read the full story

Settlement agreement reached between pharma alliances, Mylan

Tags: , , , , ,

Mylan Pharmaceuticals and pharma alliances, Banner Pharmacaps have entered into a settlement and license agreement with Eisai and Valeant Pharmaceuticals. Read the full story

Merger & acquisition news from Valeant for $250 million

Tags: , , , ,

Valeant Pharmaceuticals has released a merger & acquisition news to acquire all of the outstanding common stock of Solta Medical for $2.92 per share in cash. Read the full story

Valeant eyes more acquisitions or merger of equals

Tags: , , ,

Valeant Pharmaceuticals International continues to be on the lookout for other specialty areas after its blockbuster deal to buy eye-care giant Bausch & Lomb Read the full story